Testing effectiveness (Phase 2)Looking for participantsNCT07161258
What this trial is testing
A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS)
Who this might be right for
Relapsing Multiple Sclerosis
Hoffmann-La Roche 12